Tuberculosis infection in drug users: Interferon-gamma release assay performance

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 11, 2007, Pages 1183-1189

  Grimes, C Z ^a   Hwang, L Y ^a   Williams, M L ^a   Austin, C M ^b   Graviss, Edward A ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Crack cocaine; Interferon gamma release assay; Tuberculin skin test; Tuberculosis

Indexed keywords

COCAINE; GAMMA INTERFERON;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HIGH RISK POPULATION; HUMAN; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SMOKING; TUBERCULIN TEST;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS;

EID: 36348939313     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Taylor Z, Nolan C M, Blumberg H M, American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54: 1-81.
2. Salomon N, Perlman D C, Friedmann P, Ziluck V, Des Jarlais D C. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis 2000; 4: 47-54.
3. Malotte C K, Hollingshead J R, Rhodes F. Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med 1999; 16: 182-188.
4. Durante A J, Selwyn P A, O'Connor P G. Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment. Addiction 1998; 93: 1393-1401.
5. Howard A A, Klein R S, Schoenbaum E E, Gourevitch M N. Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis 2002; 35: 1183-1190.
6. Brassard P, Bruneau J, Schwartzman K, Senecal M, Menzies D. Yield of tuberculin screening among injection drug users. Int J Tuberc Lung Dis 2004; 8: 988-993.
7. Menzies D, Madhukar P, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
8. Kimura M, Converse P J, Astemborski J, et al. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis 1999; 179: 1297-1300.
9. Converse P J, Jones S L, Astemborski J, Vlahov D, Graham N M. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis 1997; 176: 144-150.
10. Fietta A, Meloni F, Cascina A, et al. Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Am J Infect Control 2003; 31: 347-353.
11. Mazurek G H, LoBue P A, Daley C L, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
12. Pottumarthy S, Morris A J, Harrison A C, Wells V C. Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. J Clin Microbiol 1999; 37: 3229-3232.
13. Lee J Y, Choi H J, Park I N, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28: 24-30.
14. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334.
15. Rangaka M X, Wilkinson K A, Seldon R, et al. Effect of HIV-1 infection on T cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175: 514-520.
16. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. Guidelines for using the QuantiFERON®-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54 (RR-15). http://www. cdc.gov/mmwr/pdf/rr/rr5415.pdf Accessed August 2007.
17. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
18. Shah S S, McGowan J P, Klein R S, Converse P J, Blum S, Gourevitch M N. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users. Med Sci Monit 2006; 12: MT 11-16.
19. Luetkemeyer A F, Charlebois E D, Flores L L, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175: 737-742.
20. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen L R, Ravn P. Latent tuberculosis in HIV-positive, diagnosed by the M. tuberculosis-specific interferon-gamma test. Respir Res 2006; 7: 56.
21. Dewan P K, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura L M. Feasibility, acceptability and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis 2006; 6: 47.
22. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007; 131: 1424-1434.
23. Diel R, Wrighton-Smith P, Zellweger J P. Cost-effectiveness of IGRA testing for the treatment of latent tuberculosis in Switzerland. Eur Respir J 2007; 30: 321-322.
24. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007; 11: 16-26.
25. Wrighton-Smith P, Zellweger P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006; 28: 45-50.